Bridgewater Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45M | Buy |
46,284
+24,764
| +115% | +$1.85M | 0.01% | 369 |
|
|
2025
Q1 | $1.37M | Buy |
21,520
+16,128
| +299% | +$1.02M | 0.01% | 490 |
|
|
2024
Q4 | $421K | Sell |
5,392
-2,434
| -31% | -$190K | ﹤0.01% | 595 |
|
|
2024
Q3 | $629K | Sell |
7,826
-35,747
| -82% | -$2.87M | ﹤0.01% | 666 |
|
|
2024
Q2 | $3.6M | Sell |
43,573
-3,206
| -7% | -$265K | 0.02% | 419 |
|
|
2024
Q1 | $3.99M | Sell |
46,779
-7,960
| -15% | -$679K | 0.02% | 407 |
|
|
2023
Q4 | $4.68M | Sell |
54,739
-5,413
| -9% | -$463K | 0.03% | 374 |
|
|
2023
Q3 | $5.39M | Buy |
60,152
+4,957
| +9% | +$444K | 0.03% | 351 |
|
|
2023
Q2 | $4.7M | Sell |
55,195
-6,434
| -10% | -$548K | 0.03% | 320 |
|
|
2023
Q1 | $5.1M | Buy |
61,629
+2,102
| +4% | +$174K | 0.03% | 306 |
|
|
2022
Q4 | $4.68M | Sell |
59,527
-21,454
| -26% | -$1.69M | 0.03% | 372 |
|
|
2022
Q3 | $6M | Sell |
80,981
-64
| -0.1% | -$4.74K | 0.03% | 343 |
|
|
2022
Q2 | $5.28M | Buy |
81,045
+7,552
| +10% | +$492K | 0.02% | 470 |
|
|
2022
Q1 | $4.65M | Buy |
73,493
+17,518
| +31% | +$1.11M | 0.02% | 491 |
|
|
2021
Q4 | $2.97M | Buy |
55,975
+8,306
| +17% | +$441K | 0.02% | 406 |
|
|
2021
Q3 | $3.37M | Sell |
47,669
-4,236
| -8% | -$299K | 0.02% | 352 |
|
|
2021
Q2 | $3.46M | Buy |
+51,905
| New | +$3.46M | 0.02% | 400 |
|